Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
1.190
-0.010 (-0.83%)
At close: Sep 1, 2026
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $2.15 million as of September 2, 2026. Its market cap has decreased by -31.10% in one year.
Market Cap
2.15M
Enterprise Value
1.59M
Revenue
n/a
Ranking
n/a
PE Ratio
0.40
Stock Price
$1.19
ChartMarket Cap Chart
Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from 9.64M to 2.15M, a decrease of -77.65%. That is a compound annual growth rate of -68.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 2.15M | -14.36% |
| Dec 31, 2025 | 2.52M | -73.91% |
| May 19, 2025 | 9.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eastgate Biotech | 3.17M |
| Enzolytics | 2.90M |
| BioAtla | 2.89M |
| International Stem Cell | 2.80M |
| Vaccinex | 2.68M |
| CASI Pharmaceuticals | 2.65M |
| Bioxytran | 2.59M |
| AccuStem Sciences | 2.57M |